Podophyllotoxin (PPT) is the active ingredient in Podofilox, a medical cream used to treat genital warts and molluscum contagiosum.[2] It is not recommended for HPV infections without external warts.[2] It can be applied either by a healthcare provider or the patient themselves.[2]
Podophyllotoxin was first isolated in pure form in 1880 by Valerian Podwyssotzki (1818 – 28 January 1892), a Polish-Russian privatdozent at the University of Dorpat (now Tartu, Estonia) and assistant at the Pharmacological Institute there.[6][7][8]
^ abc"Podofilox". The American Society of Health-System Pharmacists. Retrieved 8 December 2016.
^Xu H, Lv M, Tian X (2009). "A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007". Current Medicinal Chemistry. 16 (3): 327–49. doi:10.2174/092986709787002682. PMID19149581.
^"Podophyllum Resin". The American Society of Health-System Pharmacists. Retrieved 8 December 2016.
Podwyssotzki V (1880). "Pharmakologische Studien über Podophyllum peltatum" [Pharmacological studies of Podophyllum peltatum]. Archiv für experimentelle Pathologie und Pharmakologie (in German). 13 (1–2): 29–52. doi:10.1007/BF01833268. S2CID33803976. Podwyssotzki named podophyllotoxin on p. 30: " … ich nenne sie bis auf weiteres Podophyllotoxin." ( … for the time being I call it "podophyllotoxin".)
^World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.